The Patent Finder

Sanofi Vaccines US Inc.

34 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
5
Ending by 2030
Sep 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 25, 2027
    The maintenance fee for Neisseria Meningitidis Vaccine (US 11,707,514) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
  • 1 fee due Mar 15, 2027
    The maintenance fee for Stabilization of Vaccines by Lyophilization (US 9,132,184) comes due Mar 15, 2027. Unpaid by Sep 15, 2027, it lapses early.
  • 2 fees due Apr 3, 2027
  • 1 fee due May 28, 2027
    The maintenance fee for Methods of Optimizing Nucleotide Sequences Encoding Engineered Influenza Proteins (US 11,827,668) comes due May 28, 2027. Unpaid by Nov 29, 2027, it lapses early.
  • 1 fee due Aug 20, 2027
    The maintenance fee for Modification of Engineered Influenza Hemagglutinin Polypeptides (US 11,904,012) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
  • 1 fee due Sep 10, 2027
    The maintenance fee for Engineered Influenza Antigenic Polypeptides and Immunogenic Compositions Thereof (US 10,584,148) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.
  • 1 fee due Oct 26, 2027
    The maintenance fee for Pharmaceutical Compositions Containing Clostridium Difficile Toxoids A and B (US 9,320,790) comes due Oct 26, 2027. Unpaid by Apr 26, 2028, it lapses early.
  • 1 fee due Nov 5, 2027
    The maintenance fee for Pharmaceutical Compositions Containing Clostridium Difficile Toxoids a and B (US 10,639,362) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,687,541Pharmaceutical Compositions Containing Clostridium Difficile Toxoids a and B
In force
 · Medium confidence
In forceMedium confidence
US 10,639,362Pharmaceutical Compositions Containing Clostridium Difficile Toxoids a and B
In force
 · High confidence
In forceHigh confidence
US 9,023,319Vaccine
In force
 · High confidence
In forceHigh confidence
US 9,132,184Stabilization of Vaccines by Lyophilization
In force
 · High confidence
In forceHigh confidence
US 9,320,790Pharmaceutical Compositions Containing Clostridium Difficile Toxoids A and B
In force
 · High confidence
In forceHigh confidence
US 10,160,797Antibodies Against Clostridium Difficile Toxins and Methods of Using the Same
In force
 · High confidence
In forceHigh confidence
US 11,220,537Antibodies Against Clostridium Difficile Toxins and Methods of Using the Same
In force
 · Medium confidence
In forceMedium confidence
US 11,419,930Compositions and Methods for Immunizing Against C. Difficile
In force
 · Low confidence
In forceLow confidence
US 12,116,402Antibodies Against Clostridium Difficile Toxins and Methods of Using the Same
In force
 · Medium confidence
In forceMedium confidence
US 10,584,148Engineered Influenza Antigenic Polypeptides and Immunogenic Compositions Thereof
In force
 · High confidence
In forceHigh confidence
10 of 34 patents shown.
Pro members see all 34.
Pro members: see all 34 patents
Also on record, not counted in the 34: 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited